Novartis AG Chief Reshapes Drugmaker For "Brutal" New World
Novartis Chief Executive Joe Jimenez is taking a hard look at the drugmaker's smaller businesses as he reshapes the company for what he expects to be a "brutal" new era in healthcare spending. At least one of the three sub-scale units - animal health, vaccines and over-the-counter medicines - is not expected to make the cut, he told Reuters in the clearest indication yet of how the review is progressing. "I really wish we could make all three of those businesses global scale, but I think it's unlikely," Jimenez said.
Help employers find you! Check out all the jobs and post your resume.